Stay updated on GLPG2451 and GLPG2222 Combination in CF Clinical Trial
Sign up to get notified when there's something new on the GLPG2451 and GLPG2222 Combination in CF Clinical Trial page.

Latest updates to the GLPG2451 and GLPG2222 Combination in CF Clinical Trial page
- Check2 days agoChange DetectedLakefront Biotherapeutics NV is now listed as sponsor, replacing Galapagos NV. This indicates a shift in the organization responsible for the trial's conduct and governance.SummaryDifference0.2%

- Check9 days agoChange DetectedThe study record shows a new revision identifier, updating from v3.5.3 to v3.5.4, indicating a minor update to the ClinicalTrials.gov entry.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe site’s interface/version revision marker at the bottom of the page was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision: v3.5.0 is now displayed, replacing v3.4.3. This appears to be an internal version update and does not alter the study information or user workflow.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. The change appears to be a metadata/version update and does not modify study details or content.SummaryDifference0.0%

Stay in the know with updates to GLPG2451 and GLPG2222 Combination in CF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG2451 and GLPG2222 Combination in CF Clinical Trial page.